Extracellular vesicle-derived AEBP1 mRNA as a novel candidate biomarker for diabetic kidney disease

Abstract

Our results confirmed that the AEBP1 level from plasma EVs could differentiate DKD patients from T2DM patients and control subjects and was a good indication of the function of multiple critical clinical parameters. The AEBP1 level of EVs may serve as a novel and efficacious biomarker for DKD diagnosis.